Table 3. Function of CD3⁺CD56⁺ T lymphocytes in the peripheral blood of patients with AML, ALL, CR-AML, CR-ALL, and healthy controls.

	Perforin	P*
Healthy control	63.8% ± 7.10%	< 0.05
AML	26.1% ± 3.34%	< 0.05
ALL	21.2% ± 4.23%	< 0.05
CR-AML	13.2% ± 4.81%	< 0.05
CR-ALL	27.3% ± 2.70%	< 0.05

AL, acute leukemia; CR, complete remission; AML, acute myeloid leukemia; ALL, acute lymphocytic leukemia. *P < 0.05 in one-way ANOVA